It is assumed that signal transducer and activator of transcription 3 (Stat3) and the immunoregulatory cytokine interleukin 10 (IL-10) may play an important role in immune dysregulation in CTCL. The gene discussed is IL10; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.